Magura Stephen, Rosenblum Andrew, Fong Chunki
The Evaluation Center Western Michigan University Kalamazoo, Michigan, USA.
Open Addict J. 2011 Nov 11;4:58-64. doi: 10.2174/1874941001104010058.
Substance misuse is usually associated with poorer psychiatric medication adherence among psychiatric patients. Identifying predictors of medication adherence among patients with dual psychiatric and substance misuse problems is important because poor adherence is associated with relapse and re-hospitalization. The subjects were patients newly admitted to a psychiatric outpatient program who were prescribed psychiatric medication from different providers during the six months prior to admission; all also had substance misuse histories (N=131). Confidential research interviews were conducted that included a modified Medication Adherence Rating Scale (MARS) and drug toxicologies. Age (mean): 39 y; male 61%; Black 41%; Hispanic 38%; White 21%; completed high school/GED 41%; DSM-IV diagnoses: major depression 26%, schizoaffective 21%, bipolar 16%, schizophrenia 13%, other 24%; positive drug toxiology 55%. Potentially malleable factors correlated with lower adherence were: lower friends' support for drug/alcohol abstinence, more recovery-promoting behaviors, lower satisfaction with medication, more medication side effects, lower self-efficacy for drug avoidance, and lower social support for recovery. In multivariate regression analysis, only the last three factors remained as significant predictors of adherence. Low adherence is not attributable to simply forgetting to take medication. Strengthening adherence should also include better education about side effects and the importance of adherence to sustain the benefits of medication. Psychiatrists and other medical providers should also be encouraged to address patients' adherence strategies, since the time devoted to addressing that during treatment may prevent serious adverse events such as relapse to substance abuse, treatment drop-out and re-hospitalization.
药物滥用通常与精神科患者较差的精神科药物依从性相关。识别同时存在精神疾病和药物滥用问题的患者的药物依从性预测因素很重要,因为依从性差与病情复发和再次住院有关。研究对象为新进入精神科门诊项目的患者,这些患者在入院前六个月内由不同提供者开具精神科药物;他们均有药物滥用史(N = 131)。进行了保密的研究访谈,包括改良的药物依从性评定量表(MARS)和药物毒理学检测。年龄(均值):39岁;男性占61%;黑人占41%;西班牙裔占38%;白人占21%;完成高中学业/获得同等学历证书的占41%;《精神疾病诊断与统计手册》第四版(DSM-IV)诊断结果:重度抑郁症占26%,分裂情感性障碍占21%,双相情感障碍占16%,精神分裂症占13%,其他占24%;药物毒理学检测呈阳性的占55%。与较低依从性相关的潜在可变因素包括:朋友对戒酒/戒毒的支持较少、更多促进康复的行为、对药物的满意度较低、更多药物副作用、避免药物使用的自我效能较低以及康复的社会支持较低。在多变量回归分析中,只有最后三个因素仍然是依从性的显著预测因素。依从性低并非仅仅归因于忘记服药。加强依从性还应包括更好地开展关于副作用以及坚持服药以维持药物疗效重要性的教育。还应鼓励精神科医生和其他医疗服务提供者关注患者的依从性策略,因为在治疗期间投入时间解决这一问题可能会预防诸如药物滥用复发、治疗中断和再次住院等严重不良事件。